BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27774726)

  • 1. During warfarin induction, the Fiix-prothrombin time reflects the anticoagulation level better than the standard prothrombin time.
    Jonsson PI; Letertre L; Juliusson SJ; Gudmundsdottir BR; Francis CW; Onundarson PT
    J Thromb Haemost; 2017 Jan; 15(1):131-139. PubMed ID: 27774726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of factors II and X during coumarin anticoagulation and their combined measurement with a new Fiix-prothrombin time.
    Gudmundsdottir BR; Francis CW; Bjornsdottir AM; Nellbring M; Onundarson PT
    Thromb Res; 2012 Oct; 130(4):674-81. PubMed ID: 22225856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ignoring instead of chasing after coagulation factor VII during warfarin management: an interrupted time series study.
    Oskarsdottir AR; Gudmundsdottir BR; Jensdottir HM; Flygenring B; Palsson R; Onundarson PT
    Blood; 2021 May; 137(20):2745-2755. PubMed ID: 33512454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial.
    Onundarson PT; Francis CW; Indridason OS; Arnar DO; Bjornsson ES; Magnusson MK; Juliusson SJ; Jensdottir HM; Vidarsson B; Gunnarsson PS; Lund SH; Gudmundsdottir BR
    Lancet Haematol; 2015 Jun; 2(6):e231-40. PubMed ID: 26688233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trial.
    Oskarsdóttir AR; Gudmundsdottir BR; Indridason OS; Lund SH; Arnar DO; Bjornsson ES; Magnusson MK; Jensdottir HM; Vidarsson B; Francis CW; Onundarson PT
    J Thromb Thrombolysis; 2017 May; 43(4):550-561. PubMed ID: 28214948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q; Kim JE; Hyun J; Han KS; Kim HK
    Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article.
    Onundarson PT; Palsson R; Witt DM; Gudmundsdottir BR
    Thromb J; 2021 Oct; 19(1):72. PubMed ID: 34654442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The need for an adapted initiation nomogram during Fiix prothrombin time monitoring of warfarin.
    Onundarson PT; Gudmundsdottir BR
    J Thromb Thrombolysis; 2019 Nov; 48(4):685-689. PubMed ID: 31401717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding risk in warfarinized patients with a therapeutic international normalized ratio: the effect of low factor IX levels.
    Dargaud Y; Hoffman M; Lefrapper L; Lin FC; Genty A; Chatard B; Marin S; Négrier C; Monroe DM
    J Thromb Haemost; 2013 Jun; 11(6):1043-52. PubMed ID: 23581252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring anticoagulation in patients with an unreliable prothrombin time/international normalized ratio: factor II versus chromogenic factor X testing.
    Baumann Kreuziger LM; Datta YH; Johnson AD; Zantek ND; Shanley R; Reding MT
    Blood Coagul Fibrinolysis; 2014 Apr; 25(3):232-6. PubMed ID: 24681704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fiix-prothrombin time monitoring improves warfarin anticoagulation outcome in atrial fibrillation: a systematic review of randomized trials comparing Fiix-warfarin or direct oral anticoagulants to standard PT-warfarin.
    Onundarson PT; Arnar DO; Lund SH; Gudmundsdottir BR; Francis CW; Indridason OS
    Int J Lab Hematol; 2016 May; 38 Suppl 1():78-90. PubMed ID: 27426862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndrome.
    Efthymiou M; Lawrie AS; Mackie I; Arachchillage D; Lane PJ; Machin S; Cohen H
    Thromb Res; 2015 Jun; 135(6):1191-7. PubMed ID: 25895847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single test to assay warfarin, dabigatran, rivaroxaban, apixaban, unfractionated heparin, and enoxaparin in plasma.
    Letertre LR; Gudmundsdottir BR; Francis CW; Gosselin RC; Skeppholm M; Malmstrom RE; Moll S; Hawes E; Francart S; Onundarson PT
    J Thromb Haemost; 2016 May; 14(5):1043-53. PubMed ID: 26924677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin monitoring with viscoelastic haemostatic assays, thrombin generation, coagulation factors and correlations to Owren and Quick prothrombin time.
    Nilsson CU; Strandberg K; Reinstrup P
    Scand J Clin Lab Invest; 2018 Sep; 78(5):358-364. PubMed ID: 29792060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Accuracy and reliability of international normalized ratio (INR) in monitoring of warfarin--comparison in the sensitivity to extrinsic coagulation factors between PT (INR) and TT (INR)].
    Sakayori T; Naito S; Yoshida M; Kumano O; Kato N; Okuda M; Ieko M
    Rinsho Byori; 2010 Aug; 58(8):779-85. PubMed ID: 20860170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose.
    Holland L; Warkentin TE; Refaai M; Crowther MA; Johnston MA; Sarode R
    Transfusion; 2009 Jun; 49(6):1171-7. PubMed ID: 19210325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparative Study of Point-of-Care Prothrombin Time in Cardiopulmonary Bypass Surgery.
    Okabayashi S; Ogawa S; Tanaka KA; Nishiyama T; Takeshita S; Nakayama Y; Nakajima Y; Sawa T; Mizobe T
    J Cardiothorac Vasc Anesth; 2018 Aug; 32(4):1609-1614. PubMed ID: 29395816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the capacities of two prothrombin complex concentrates to restore thrombin generation in plasma from orally anticoagulated patients: an in vitro study.
    Dargaud Y; Desmurs-Clavel H; Marin S; Bordet JC; Poplavsky JL; Negrier C
    J Thromb Haemost; 2008 Jun; 6(6):962-8. PubMed ID: 18373620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin.
    Yamamoto R; Nakae Y; Tanaka F; Johkura K
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1781-1785. PubMed ID: 27103270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.